1-2 of 2
Von Potter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: A Phase 2, Open-Label Study Evaluating the Safety and Efficacy of the PKR Activator Etavopivat (FT-4202) in Patients with Thalassemia or Sickle Cell Disease

Ashutosh Lal, R. Clark Clark Brown, Thomas D. Coates, Theodosia A. Kalfa, Janet L. Kwiatkowski, Julie Brevard, Von Potter, Ken W. Wood, Sujit Sheth
Journal: Blood
Blood (2021) 138 (Supplement 1): 4162.
https://doi.org/10.1182/blood-2021-145752
Published: 2021
Journal Articles

A Phase 1 Trial of Vorinostat and Pegylated Liposomal Doxorubicin In Relapsed or Refractory Lymphoma.

Frederick Lansigan, MD, Stuart Seropian, MD, Dennis L. Cooper, MD, Von Potter, MD, Noelle Sowers, RN, Francine M Foss, MD
Journal: Blood
Blood (2010) 116 (21): 2816.
https://doi.org/10.1182/blood.V116.21.2816.2816
Published: 2010